Hansen's Disease and Complications among Marshallese Persons Residing in Northwest Arkansas, 2003-2017
- PMID: 32901601
- PMCID: PMC7646809
- DOI: 10.4269/ajtmh.20-0003
Hansen's Disease and Complications among Marshallese Persons Residing in Northwest Arkansas, 2003-2017
Abstract
Persons from the Republic of the Marshall Islands have among the highest rates of Hansen's disease (HD) in the world; the largest Marshallese community in the continental United States is in northwest Arkansas. In 2017, the HD Ambulatory Care Clinic in Springdale, Arkansas, informed the Arkansas Department of Health (ADH) that Marshallese persons with HD had severe disease with frequent complications. To characterize their illness, we reviewed ADH surveillance reports of HD among Marshallese persons in Arkansas treated during 2003-2017 (n = 42). Hansen's Disease prevalence among Marshallese in Arkansas (11.7/10,000) was greater than that in the general U.S. population. Complications included arthritis (38%), erythema nodosum leprosum (21%), and prolonged treatment lasting > 2 years (40%). The majority (82%) of patients treated for > 2 years had documented intermittent therapy. Culturally appropriate support for therapy and adherence is needed in Arkansas.
Conflict of interest statement
Disclaimer: The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the CDC or the Arkansas Department of Health.
Similar articles
-
Notes from the Field: Cluster of Tuberculosis Cases Among Marshallese Persons Residing in Arkansas - 2014-2015.MMWR Morb Mortal Wkly Rep. 2016 Aug 26;65(33):882-3. doi: 10.15585/mmwr.mm6533a7. MMWR Morb Mortal Wkly Rep. 2016. PMID: 27560201
-
Tuberculosis and leprosy infections in the Marshallese population of Arkansas, USA.Lepr Rev. 2016 Mar;87(1):109-12. Lepr Rev. 2016. PMID: 27255065
-
Community Health Warriors: Marshallese Community Health Workers' Perceptions and Experiences with CBPR and Community Engagement.Prog Community Health Partnersh. 2017;11(3):315-320. doi: 10.1353/cpr.2017.0037. Prog Community Health Partnersh. 2017. PMID: 29056624
-
Treatment of leprosy/Hansen's disease in the early 21st century.Dermatol Ther. 2009 Nov-Dec;22(6):518-37. doi: 10.1111/j.1529-8019.2009.01274.x. Dermatol Ther. 2009. PMID: 19889136 Review.
-
Hansen's disease (Leprosy): current and future pharmacotherapy and treatment of disease-related immunologic reactions.Pharmacotherapy. 2012 Jan;32(1):27-37. doi: 10.1002/PHAR.1009. Pharmacotherapy. 2012. PMID: 22392826 Review.
Cited by
-
Precision information extraction for rare disease epidemiology at scale.J Transl Med. 2023 Feb 28;21(1):157. doi: 10.1186/s12967-023-04011-y. J Transl Med. 2023. PMID: 36855134 Free PMC article.
-
Moana: Alternate surveillance for COVID-19 in a Unique Population (MASC-UP).Contemp Clin Trials Commun. 2023 Dec 20;37:101246. doi: 10.1016/j.conctc.2023.101246. eCollection 2024 Feb. Contemp Clin Trials Commun. 2023. PMID: 38222877 Free PMC article.
-
COVID-19 Disparities Among Marshallese Pacific Islanders.Prev Chronic Dis. 2021 Jan 7;18:E02. doi: 10.5888/pcd18.200407. Prev Chronic Dis. 2021. PMID: 33411668 Free PMC article. No abstract available.
References
-
- Britton WJ, Lockwood DNJ, 2004. Leprosy. Lancet 363: 1209–1219. - PubMed
-
- Pereira HLA, Ribeiro SLE, Pennini SN, Sato EI, 2009. Leprosy-related joint involvement. Clin Rheumatol 28: 79–84. - PubMed
-
- Vengadakrishnan K, Saraswat PK, Mathur PC, 2004. A study of rheumatological manifestations of leprosy. Indian J Dermatol Venereol Leprol 70: 76–78. - PubMed
-
- World Health Organization , 2018. Leprosy - Registered Cases Per 10 000 Population Data by Country. Available at: http://apps.who.int/gho/data/node.main.NTDLEPR4?lang=en. Accessed July 17, 2019.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical